Innocoll has secured European approval for its CollaGUARD surgical adhesion barrier for the prevention of postoperative adhesions following abdominal and pelvic surgery.
CollaGUARD is a transparent bioresorbable film of 100% type I collagen, developed using Innocoll’s proprietary CollaFilm technology.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The adhesion barrier is implanted at the time of surgery and serves as a temporary barrier to separate apposing adhesiogenic surfaces throughout the normal tissue repair process.
When tested in vivo, CollaGUARD increased the probability of remaining adhesion-free by more than six-fold, and reduced the extent and severity of adhesions.
The company also plans to seek approval in Australia, Canada, the Middle East, North Africa and south-east Asia.
It will also initiate the studies required for registration in the US.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
